A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HSCT / hematopoietic stem cell

[Related PubMed/MEDLINE]
Total Number of Papers: 50
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HSCT  (>> Co-occurring Abbreviation)
Long Form:   hematopoietic stem cell
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Characteristics, management, and outcome of pediatric patients with post-transplant lymphoproliferative disease-A 20 years' experience from Austria. PTLD, SOT
2020 Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive/Palliative Therapies. CNS, ERT, GAGs, MPS
2020 Two Roads Diverge: Treatment Choice in Coexisting Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria. AA, IST, PNH
2019 "Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation". CRP, PY, SIR
2019 Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review. CMV, SOT
2019 Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation. PTLD
2019 PD-L1 and PD1 expression in post-transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter- and intra-individual descriptive study covering the whole spectrum of PTLD categories. PTLD, SOT
2019 The use of comprehensive geriatric assessment in older patients before allologeneic hematopoietic stem cell transplantation: A cross-sectional study. CGA, DRI, GDS, HCT-CI, HCT-SCI, IADL
2018 Burden of severe RSV disease among immunocompromised children and adults: a 10year retrospective study. LRTI, RSV
10  2018 Classification of death causes after transplantation (CLASS): Evaluation of methodology and initial results. CLASS, CRF
11  2018 Severely bothersome fatigue in children and adolescents with cancer and hematopoietic stem cell transplant recipients. CI, OR, SSPedi
12  2018 Taste changes in children with cancer and hematopoietic stem cell transplant recipients. ALL, CI, OR, PeNAT, SSPedi
13  2017 A Review of Demographic, Medical, and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood. BMT, GVHD, HRQoL
14  2017 Current therapies for Morquio A syndrome and their clinical outcomes. ERT
15  2017 Respiratory Fungal Infections in Solid Organ and Hematopoietic Stem Cell Transplantation. ---
16  2016 Evidence for improved survival in postsymptomatic stem cell-transplanted patients with Krabbe's disease. KD
17  2015 Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation. RSV
18  2014 Impact of Enzyme Replacement Therapy and Hematopoietic Stem Cell Therapy on Growth in Patients with Hunter Syndrome. ERT
19  2014 Methods of detection of immune reconstitution and T regulatory cells by flow cytometry. ---
20  2014 Pharmacokinetic tools for the dose adjustment of ciclosporin in haematopoietic stem cell transplant patients. AUC, CsA, ITS, LSS
21  2014 Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells. AdV, CCS, CMV, EBV, HHV, SOT
22  2013 Rapid generation of EBV-specific cytotoxic T lymphocytes resistant to calcineurin inhibitors for adoptive immunotherapy. CTL, EBV, IFN-gamma, PTLD, SOT, TAC
23  2013 Role of donor and recipient sex in platelet transfusion. PLT, PPR
24  2013 The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infection. CMV, GRMs, pGRM, sGRM
25  2012 Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II. BBB, CNS, ERT, GAGs, IDS, IVA, MPS II
26  2012 Is the presence of 6 or fewer crypt apoptotic bodies sufficient for diagnosis of graft versus host disease? A decade of experience at a single institution. GVHD
27  2012 Periodontal status and post-transplantation complications following intensive periodontal treatment in patients underwent allogenic hematopoietic stem cell transplantation conditioned with myeloablative regimen. GVHD, OM
28  2011 Acute graft versus host disease in hematopoietic stem cell alotransplant recipients. GVHD
29  2011 Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years. HIV-1
30  2011 Distress screening in allogeneic hematopoietic stem cell (HSCT) caregivers and patients. BSI-18, DT, MFSI
31  2011 Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. C6S, ERT, GAGs, KS, MPS IVA
32  2008 Successful treatment of EBV PTLD with CNS lymphomas with the monoclonal anti-CD20 antibody rituximab. CNS, EBV, PTLD
33  2007 Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience. MRT
34  2007 Rehabilitation of chronic graft versus host disease in children. A clinical series. cGVHD
35  2007 Rehabilitation of therapy-related cognitive deficits in patients after hematopoietic stem cell transplantation. ---
36  2007 Trends in infections in children with malignant disease in 2000: comparison of data of 1980/81. BSI, CDI, FUO, ONC
37  2006 A related donor and reduced intensity conditioning reduces the risk of development of BK virus-positive haemorrhagic cystitis in allogeneic haematopoetic stem cell-transplanted patients. BKV, HC, RD, URD
38  2006 Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection. CMV, MVA, NAb, SOT
39  2006 EBMT activity survey 2004 and changes in disease indication over the past 15 years. ---
40  2006 [The impact of stem cell therapy in hematology and oncology]. ---
41  2005 Severe combined immunodeficiency. A model disease for molecular immunology and therapy. SCIDs
42  2005 The role of immune ablation and stem cell transplantation in severe SLE. ---
43  2004 Evolution of hematopoietic stem cell transplantation in Eastern and Western Europe from 1990 to 2003. A report from the EBMT activity survey. EBMT
44  2004 Molecular TCR diagnostics can be used to identify shared clonotypes after allogeneic hematopoietic stem cell transplantation. GVHD, TCR
45  2004 Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature. AdV
46  2003 G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV. G-CSF, GVHD
47  2002 Immunogenetic selection of donors for haematopoietic stem cell transplantation: an approach. ---
48  2001 Epstein-Barr virus-associated post-transplant lymphoproliferative disease after bone marrow transplantation mimicking graft-versus-host disease. AML, CsA, EBV, GVHD, HLA, PTLD
49  2001 Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. alpha1-MG, beta-NAG, THP
50  2000 Management of graft-versus-host disease in paediatric bone marrow transplant recipients. GVHD